Vivos Therapeutics VVOS
NASDAQ VVOS
$0.10 +0.00 (+2.24%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos Therapeutics (VVOS) Non-Current Deferred Revenue (2022 - 2025)

Updated

Analysis

Vivos Therapeutics (VVOS) Non-Current Deferred Revenue (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Vivos Therapeutics 1.68 Mn -7.36 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 97,000.00
Sep 30, 2024 178,000.00
Jun 30, 2024 352,000.00
Mar 31, 2024 533,000.00
Dec 31, 2023 289,000.00
Sep 30, 2023 240,000.00
Jun 30, 2023 264,000.00
Mar 31, 2023 250,000.00
Dec 31, 2022 112,000.00
Sep 30, 2022 180,000.00
Jun 30, 2022 317,000.00
Mar 31, 2022 375,000.00
API Access

Vivos Therapeutics Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VVOS&period=max&api_key=YOUR_API_KEY